The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Oct. 30, 6:54 PM

Slide #2. Inogen Secondary Offering

Company: Inogen (NASDAQ:INGN)
Date announced: 10/27/2014
Shares Offered: 2,100,775
Date of Pricing: 10/29/2014
Price Per Share: $21.50
Secondary Offering Details: Inogen, Inc. (Nasdaq:INGN) today announced the pricing of 2,100,775 shares of its common stock at $21.50 per share in a secondary offering. All of the shares will be sold by existing stockholders. In addition, the underwriters have a 30-day option to purchase up to 315,116 additional shares of common stock from the selling stockholders.

Inogen is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Co.'s proprietary Inogen One systems concentrate the air around the patient to provide a single source of supplemental oxygen with a portable device weighing approximately 4.8 or seven pounds. Co.'s Inogen One G3 and G2 have up to 4.5 and five hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Open the INGN Page at The Online Investor »

Company Name:  Inogen, Inc
Sector:  Medical Instruments & Supplies
Number of ETFs Holding INGN:  12
Total Market Value Held by ETFs:  $2.93M
Total Market Capitalization:  $411.00M
% of Market Cap. Held by ETFs:  0.71%

Open the INGN Page at The Online Investor (in a new window) »

October 30, 2014    6:54 PM Eastern
Quotes delayed 20 minutes

Strong Buy (3.50 out of 4)
73rd percentile
(ranked higher than approx. 73% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.